Positioning Imatinib for Pulmonary Arterial Hypertension
NCT04416750
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
Imatinib Mesylate
Sponsor
Imperial College London
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]